{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:39:56Z","timestamp":1792593596062,"version":"4.5.0"},"reference-count":0,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The recommended access for starting chronic hemodialysis (HD) is an arteriovenous fistula (AVF), but a (CVC) continues to be frequently used. Worldwide, its use has been associated with higher mortality, but data from Brazil are lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Analytical, observational, and retrospective cohort study that aimed at analyzing the data available in the Brazilian Monthly Dialysis Registry database from Jan\/2011 to Dec\/2023. Using data from this registry, we evaluated the frequency of CVC use (regardless of whether tunneled or non-tunneled) at the start of HD across 13 years and assessed its impact on all-cause mortality over 2 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We studied 10,182 patients. The mean age was 59 (47-69) years; 59% were male, and 33% had diabetes. CVC use at HD entry increased substantially in the last 10 years. The 2-year mortality rates for CVC and primary AVF\/graft users were 20% and 9%, respectively, P &amp;lt; 0.001. In the fully adjusted multivariate model, the use of CVC persisted significantly associated with mortality (HR 1.69, 95%CI 1.23-2.25, P=0.001). Other variables directly associated with mortality were age (HR 1.04, 95%CI 1.03-1.05, P=0.001), and serum ferritin (HR 1.18, 95%CI 1.06-1.30, P=0.002). Serum albumin (HR 0.86, 95%CI 0.84-0.88, P&amp;lt;0.001) and URR (HR 0.97, 95%CI 0.96-0.97, P&amp;lt;0.001) emerged as protective factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CVC use was associated with a 1.69-fold increased risk of 2-year mortality. The increasing use of CVCs in Brazil is concerning and highlights the need for public health strategies promoting timely permanent vascular access before HD initiation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/joneph\/aajag259","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:49:43Z","timestamp":1792590583000},"source":"Crossref","is-referenced-by-count":0,"title":["Use of a central venous catheter as vascular access at the start of a regular hemodialysis program: impact on mortality over 2 years"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9863-1203","authenticated-orcid":false,"given":"Ang\u00e9lica Pe\u00e7anha","family":"da Silva","sequence":"first","affiliation":[{"name":"Postgraduation program in Medical Sciences, School of Medicine, Universidade Federal Fluminense , Niter\u00f3i, Rio de Janeiro ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana B","family":"Nerbass","sequence":"additional","affiliation":[{"name":"Nephrology Division, Funda\u00e7\u00e3o Pro-rim , Joinville, Santa Catarina ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helbert do Nascimento","family":"Lima","sequence":"additional","affiliation":[{"name":"Universidade da Regi\u00e3o de Joinville , Joinville, Santa Catarina ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo C","family":"Sesso","sequence":"additional","affiliation":[{"name":"Nephrology Division, Department of Medicine, School of Medicine, Universidade Federal de S\u00e3o Paulo , S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocemir R","family":"Lugon","sequence":"additional","affiliation":[{"name":"Nephrology Division, Department of Medicine, School of Medicine, Universidade Federal Fluminense , Niter\u00f3i, Rio de Janeiro ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,21]]},"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/joneph\/advance-article-pdf\/doi\/10.1093\/joneph\/aajag259\/72252797\/aajag259.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/joneph\/advance-article-pdf\/doi\/10.1093\/joneph\/aajag259\/72252797\/aajag259.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:49:44Z","timestamp":1792590584000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/advance-article\/doi\/10.1093\/joneph\/aajag259\/8964978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1093\/joneph\/aajag259","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"article-number":"aajag259"}}